The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Tech Talk: Contraption Reduces Pain of Rheumatic Therapy Injections

Tech Talk: Contraption Reduces Pain of Rheumatic Therapy Injections

May 1, 2013 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • Tech Talk: Tapping Computer Power to Promote Physical Therapy
  • Tech Talk: Apps Put More Rheumatology Information at Fingertips
  • Tech Talk: New Technologies Attempt to Find Better Treatments for Rheumatic Diseases
Explore This Issue
May 2013
Also By This Author
  • 2015 ACR/ARHP Annual Meeting: Novel Approaches for Intra-Articular Arthritis Therapy
Contraption buzzing away the pain of rheumatic therapy injections
A patient prepares to get an IV infusion with Buzzy.


One early morning in the summer of 2004, as she was driving home from an overnight shift at the hospital, Amy Baxter, MD, came up with a simple—but, she thought, powerful—idea.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Her son had just had a horrible experience getting a shot. But did the age-old tradition of terrified, crying children being tugged into the pediatrician’s office really have to be the tradition?

What if vibration and cold were applied near the injection site to, in essence, snuff out much of the pain of the needle?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Panacea for Needle Phobia

Dr. Baxter worked on the idea for a while and soon, Buzzy was born. It’s a contraption that applies a high-frequency vibration sensation near the injection site, along with ice, that cuts down the amount of pain by about 50% in children. Buzzy was originally made in the form of a happy, cartoon bee to appeal to children, but Baxter soon found that it works even better for adults, including rheumatology patients needing weekly injections: In adults, it reduces the pain by about 80%, the company’s research has found.

She was able to develop and manufacture Buzzy with a $1-million federal Small Business Innovation Research grant. The first Buzzy, which costs $39.95, was sold in 2009. And there are now 22,000 users, says Baxter, a pediatric pain physician and researcher.

It is sold mostly to patients and to hospitals, which use it mostly for IV access. But among specific diseases, rheumatology ranks near the top of the list, Baxter says.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“Buzzy has unquestionably gotten people over the fear of needles,” she says. “My kids don’t even ask anymore, ‘Am I going to get a shot?’ They just say, ‘Did you bring Buzzy?’ ”

A 2012 survey study out of the University of Toronto found that 24% of parents and 63% of children report a fear of needles. And that fear was the main reason for noncompliance with immunization in 7% of parents and 8% of children, the study found. The authors suggested a wider education about interventions that ease pain during injections.1

“We’re raising a generation of needle-phobic kids, and once they’re old enough to drive themselves to the doctor, they’re not going to do it,” Dr. Baxter says. “Then we’re going to have a real problem with noncompliance.”

At first, three-quarters of Buzzy’s users were kids. Now, about two-thirds of the users are adults, she says. “A plain black version is now available for older users.”

Pages: 1 2 3 | Single Page

Filed Under: Technology Tagged With: Injection, patient care, Rheumatic Disease, TechnologyIssue: May 2013

You Might Also Like:
  • Tech Talk: Tapping Computer Power to Promote Physical Therapy
  • Tech Talk: Apps Put More Rheumatology Information at Fingertips
  • Tech Talk: New Technologies Attempt to Find Better Treatments for Rheumatic Diseases
  • Tech Talk: Smartphone Apps, Online Games May Encourage Healthy Behaviors in Rheumatology Patients

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.